Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.
Atossa Therapeutics (formerly Atossa Genetics) is a pharmaceutical company focused on the development of breast cancer therapeutics.
Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients.
Modern therapies targeting the immune synapse.
Immune Design is a clinical-stage immunotherapy company with next-generation in vivo approaches designed to enable the body’s immune system to fight disease.
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.
Adaptive Biotechnologies offers research and diagnostic tools for scientists and clinicians involved in genomic immunology.
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
PhaseRx is a biopharmaceutical company developing a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children.
Stratos Genomics develops Sequencing by Expansion (SBX™), a single-molecule detection process that enables whole genome sequencing.
Nohla is a cellular therapy company driven by a powerful vision to provide off-the-shelf treatment for critical care patients around the world.